Follow-The-Filings

Security

CGTX

Cognition Therapeutics Inc. · COM

Equity holders as of 2025 Q4 (each manager’s latest book)

4 owners 2 exits max 0.0% (Vanguard Group Inc.)

grid → activity →
owners 4
max % 0.0%
tracked value $5M
qoq A 2 R 1 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 0.0% Add 0.00 pp 3,317,525 $4M hist
Renaissance Technologies LLC 2026 Q1 stale 0.0% Add 0.00 pp 1,117,136 $848 hist
Two Sigma Investments, LP 2025 Q4 0.0% Exit 0.00 pp 47,729 $64 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 stale 0.0% Reduce 0.00 pp 25,905 $20 hist
Israel Englander - Millennium Management LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 64,657 $87 hist
Marshall Wace - Marshall Wace, LLP exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 27,577 $37 hist

4 current · 2 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — —
Gross profit — — —
Gross margin — — —
Net income -$25.79M -$33.97M -$23.49M
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $34.22M $29.56M $47.99M
Total non-current assets * $941,000 $679,000 $399,000
Total assets $35.16M $30.23M $48.39M
Total current liabilities $10.17M $11.14M $13.92M
Total non-current liabilities * $520,000 $342,000 $195,000
Total equity $24.47M $18.75M $34.27M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$16.02M -$28.47M -$24.59M
Cash from investing -$147,000 -$4,000 $9,000
Cash from financing $4.52M $23.56M $36.57M
Net change in cash -$11.64M -$4.91M $11.99M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders